Stavudine For HIV: Risks, Dosage, And Key Facts

Stavudine, marketed as Zerit, is a nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV infection by slowing viral replication and reducing virus levels in the body.

About stavudine

Stavudine belongs to the class of

nucleoside reverse transcriptase inhibitor antiretroviral medicines

(NRTIs). It is specifically indicated for

human immunodeficiency virus (HIV) infection

in adults and children when other NRTIs are not suitable.

Type of medicine	A nucleoside reverse transcriptase inhibitor antiretroviral medicine
Used for	Human immunodeficiency virus (HIV) infection, in adults and children
Also called	Zerit® (discontinued in UK)
Available as	Capsules and oral solution (primarily in US)

HIV attacks and destroys CD4 T cells, crucial white blood cells that protect against infections. Without treatment, this weakens the immune system, making the body vulnerable to opportunistic infections. Stavudine works by inhibiting the reverse transcriptase enzyme, preventing HIV from replicating its genetic material into DNA, thus acting as a chain terminator due to its lack of a 3′-OH group.

Prescribed by HIV specialists, stavudine is used short-term in

combination therapy

with at least two other antiretrovirals. Combination reduces resistance risk and enhances efficacy compared to monotherapy. In the UK, Zerit was discontinued, and globally, its use is limited due to toxicity; the European Medicines Agency (EMA) recommends it only when no alternatives exist, for the shortest duration.

Approved by the FDA in 1996, stavudine’s role has diminished with safer options available. As of 2011, only about 160 UK patients used it.

How to take stavudine

Follow your doctor’s instructions precisely. Stavudine is dosed

twice daily, every 12 hours

. Dosage depends on weight, age, and formulation (capsules 15-40 mg or oral solution 1 mg/mL).

• Take on an

  empty stomach

  —1 hour before or 2 hours after meals—for optimal absorption.
• Swallow capsules whole with water; do not chew or open.
• For oral solution, measure with syringe or cup; shake well.
• Adults: 30-40 mg twice daily (≤60 kg: 30 mg; >60 kg: 40 mg).
• Children: 1 mg/kg twice daily, adjusted by age/weight.

Read the manufacturer’s leaflet for full details and side effects list before starting. Adherence is critical; missing doses risks resistance.

Getting the most from your treatment

Attend all

regular appointments

for blood tests monitoring viral load, CD4 count, and side effects like lactate levels.

• Take exactly as prescribed, even if feeling well—HIV treatment is lifelong.
• Avoid alcohol and drugs that stress the liver.
• Use reliable contraception; discuss pregnancy plans (placental transfer occurs, breastfeeding contraindicated).
• Inform doctor of all medications to avoid interactions (e.g., contraindicated with didanosine, zidovudine).
• Safe sex and needle precautions prevent transmission.

Continue until doctor switches to alternatives, as stavudine is transitional due to toxicity.

Can stavudine cause problems?

Stavudine has

serious side effects

from mitochondrial toxicity, including

lactic acidosis

,

lipoatrophy

,

peripheral neuropathy

, and hepatotoxicity. Use only if no alternatives, shortest time possible.

Common side effects	Description	Action
Peripheral neuropathy	Numbness, tingling, pain in hands/feet	Report immediately; may resolve on stopping
Headache, nausea	GI upset, rash	Usually mild; monitor
Fatigue, insomnia	General malaise	Discuss with doctor

**Serious risks** (monitor closely):

• Lactic acidosis: Fatigue, nausea, abdominal pain, dyspnea, hyperlactatemia (>2.2x normal). Prevalence ~1% with stavudine; can mimic Guillain-Barré syndrome (LAS) with neuromuscular weakness. Stop drug immediately if suspected; may require ventilation.
• Lipoatrophy: Fat loss in face/limbs.
• Pancreatitis/hepatotoxicity: Fatal cases with didanosine/hydroxyurea.

Symptoms like those of lactic acidosis warrant urgent medical attention.

Interactions with other medicines

Stavudine interacts via renal secretion and phosphorylation inhibition.

• Contraindicated: Didanosine (mitochondrial toxicity), hydroxyurea (hepatotoxicity).
• Avoid: Zidovudine (competes activation), doxorubicin, ribavirin.
• Drugs like cimetidine may increase levels; monitor.

Always disclose all medications.

Special considerations

Pregnancy and breastfeeding

Category C; crosses placenta. Use only if benefits outweigh risks; insufficient data for MTCT prevention. HIV+ women should not breastfeed.

Children and elderly

Approved >3 months; dose by weight. Elderly: renal/hepatic adjustments.

Renal/hepatic impairment

Reduce dose if CrCl <50 mL/min; caution in liver disease.

Discontinuation and status

Discontinued in UK/EU due to risks; limited global use. Switch to safer NRTIs like tenofovir or abacavir when possible.

Frequently Asked Questions (FAQs)

Q: What is stavudine used for?

A: Stavudine (Zerit) treats HIV by inhibiting reverse transcriptase, used in combination when other NRTIs fail.

Q: How should I take stavudine?

A: Twice daily on empty stomach, every 12 hours, as prescribed.

Q: What are the main side effects?

A: Neuropathy, lactic acidosis, lipoatrophy. Monitor lactate; stop if serious symptoms.

Q: Is stavudine safe in pregnancy?

A: Only if essential; no breastfeeding.

Q: Why is Zerit discontinued in the UK?

A: High risk of severe effects like lactic acidosis; use only as last resort.

Q: Can I take stavudine with other HIV drugs?

A: Yes, in combination, but avoid didanosine, zidovudine.